Smith and Nephew and Advanced Tissue Sciences (ATS) submit Dermagraft to FDA
This article was originally published in Clinica
Executive Summary
Smith & Nephew and Advanced Tissue Sciences have submitted their Dermagraft replacement skin to the FDA for approval to market it in the US. Dermagraft is a bioengineered skin which is used to cover wounds caused by diabetic foot ulcers.